DOCSLIB.ORG

Specific Receptor for the Opioid Peptide Dynorphin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Specific Receptor for the Opioid Peptide Dynorphin Proc. Natl. Acad. Sci. USA Vol. 78, No. 10, pp. 6543-6547, October 1981 Neurobiology Specific receptor for the opioid peptide dynorphin: Structure activity relationships (myenteric plexus/opiate/endorphin/multiple opiate receptors/neuropeptide) CHARLES CHAVKIN AND AVRAM GOLDSTEIN Addiction Research Foundation and Stanford University, Palo Alto, California 94304 Contributed by Avram Goldstein, July 1, 1981 ABSTRACT The structural features responsible for the high MATERIALS AND METHODS potency and opiate receptor specificity of the opioid peptide dy- norphin in the guinea pig ileum myenteric plexus were examined. The following opioid peptides were obtained from Peninsula Successive removal of'COOH-terminal amino acids from dynor- Laboratories (San Carlos, CA): dynorphin-(1-13), dynorphin- phin-(1-13) demonstrated important contributions of lysine-13, (1-9), dynorphin-(6-13), a-N-acetyldynorphin-(6-13), lysine-11, and arginine-7 to the potency. Removal ofthe NH2-ter- [DAla2]dynorphin-(1-11), [DAla2]dynorphin-(1-13)NH2, a-N- minal tyrosine abolished the biologic activity. Several other struc- methyldynorphin-(1-13)NH2, endo-Gly'-dynorphin-(1-13), and tural modifications were shown to affect potency: substitution of [Arg8]a-neo-endorphin-(1-8). For each of these peptides, pu- D-alanine for glycine-2 reduced the potencies ofdynorphin-(1-13) rity was shown to be >98% by thin-layer chromatography, elec- amide, -(1-11), and -(1-10); and methyl esterification ofthe COOH trophoresis, and amino acid analysis, by the criteria described terminus enhanced the potencies of dynorphin-(1-12), 41-10), (1). [Leu]Enkephalin, [DAla2, Leu5]enkephalin, and -(1-9), -(1-8), and -(1-7). Within the dynorphin sequence, lysine- [Leu]enkephalin-Arg6 were obtained from Biosearch (San Ra- 11 and arginine-7 were found to be important for selectivity ofin- fael, CA). Dynorphin-(3-13) and dynorphin-(2-13)-Ser-Asp- teraction with the dynorphin receptor, which is distinguishable Asn-Gln were obtained from Peninsula Laboratories as crude from the ja receptor in this tissue. products after cleavage from the synthesizing resin. These two peptides were purified to homogeneity on C18 reverse-phase The-opioid peptide dynorphin was recently purified from por- high-pressure liquid chromatography (HPLC) as described be- cine pituitary extracts and its sequence was partially deter- low, and composition was confirmed by amino acid analysis. mined. The 13-residue peptide at its NH2 terminus, Tyr-Gly- A series of fragments was prepared with COOH-terminal Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys, was synthe- amino acids successively removed from dynorphin-(1-13) and sized and shown to contain the pharmacologically active portion from analogues with amino acid substitutions. Carboxypepti- ofthe natural material (1). In the opiate receptor bioassay using dase B (Sigma, type I, diisopropyl fluorophosphate-treated) was the guinea pig ileum myenteric plexus-longitudinal muscle used to prepare dynorphin-(1-12) and dynorphin-(1-11) from preparation, the differences between dynorphin-(1-13) and dynorphin-(1-13) and dynorphin-(1-8) from dynorphin-(1-9). [Leu]enkephalin are particularly interesting because the NH2 Trypsin (Sigma, type XI, diphenylcarbamoyl chloride-treated) terminus of dynorphin corresponds to the [Leu]enkephalin was used to prepare dynorphin-(1-7) and dynorphin-(1-6) from pentapeptide sequence. First, dynorphin-(1-13) is about 700 dynorphin-(1-13), [DA1a2]dynorphin-(1-7) and [DAa2]dynorphin- times more potent than [Leu]enkephalin; and second, the ag- (1-6) from [DAla2]dynorphin-(1-13)NH2, and endo-Gly -d onist effects ofdynorphin-(1-13) are 1/'3th as sensitive to nalox- norphin-(1-6) and endo-Gly'-dynorphin-(1-7) from endo-Gly - one antagonism (1). The higher potency of dynorphin-(1-13) dynorphin-(1-13). Prolyl endopeptidase purified from porcine indicates that the COOH-terminal extension ofthe enkephalin brain by M. Orlowski (6) was used to prepare dynorphin-(1-10) sequence [dynorphin-(6-13)] might provide additional points from and of receptor interaction. The differences in sensitivity to nalox- dynorphin-(1-11) [DAla ]dynorphin-(1-10) from one antagonism suggest that the two agonists have different [DAla2]dynorphin-(1-11). opiate receptor specificity (2); thus, the lower sensitivity ofdy- Peptides from reaction mixtures were purified by repeated norphin-(1-13) to naloxone antagonism suggested the existence passage through a C18 reverse-phase HPLC column (0.39 x 30 of a separate dynorphin receptor (1). cm, uBondapak, Waters, 15-35% linear gradient ofacetonitrile Evidence for a separate dynorphin receptor distinct from the in 5 mM trifluoroacetic acid, 1.5 ml/min) with monitoring of morphine (A) and enkephalin (8) receptors has been provided eluate at two wavelengths, 220 and 254 nm, until a single sym- by Wfister et al. (3, 4) who used the mouse vas deferens opiate metrical absorbance peak was obtained. Purity was also con- receptor bioassay. We have recently demonstrated (5) that the firmed in two different thin-layer chromatography systems dynorphin receptor is physically distinct from the ,u receptor (chloroform/methanoVacetic acid/water, 15:10:2:3, Brink- that mediates the effects ofenkephalin and normorphine in the mann Polygram 0.25-mm sil G plates; n-butanoVpyridine/ guinea pig ileum myenteric plexus. acetic acid/water, 21:12:2:15, Eastman cellulose). Concentra- In this paper we present an analysis ofpotency and receptor tions of final products were determined at 274.5 nm by using specificity in a series ofdynorphin analogues in the guinea pig Abbreviations: IC50, concentration for 50% inhibition of guinea pig ileum myenteric plexus-longitudinal muscle bioassay. ileum myenteric plexus-longitudinal muscle contraction; endo-Gly'- dynorphin-(1-13) has glycine inserted after leucine-5 in the dynorphin- The publication costs ofthis article were defrayed in part by page charge (1-13) sequence; HPLC, high-pressure liquid chromatography. payment. This article must therefore be hereby marked "advertise- Throughout this paper, unless otherwise indicated, peptide abbrevia- ment" in accordance with 18 U. S. C. §1734 solely to indicate this fact. tions signify free NH2 and COOH termini. 6543 Downloaded by guest on September 26, 2021 6544 Neurobiology: Chavkin and Goldstein Proc. Nad Acad. Sci. USA 78 (1981) the tyrosine extinction coefficient, 1340, and confirmed by chain length, however, has the additional effect of introducing molar yields in amino acid analysis. Identities offragments were a negatively charged COOH-terminal acidic group into a novel confirmed by amino acid composition analysis (Dionex analyzer position in the binding site. To eliminate this confounding con- with fluorescence detection) after hydrolysis at 110°C for 24 hr tribution, we removed the negative charge from each of the in 6 M HG1 (sealed tube with argon). Mole ratios were computed peptide fragments by converting the acids to their methyl relative to arginine, with a hydrolysate. of dynorphin(1-13) or esters. [DAla2]dynorphin-(1-13)NH2 prepared and analyzed concur- The IC50 values (and confidence intervals) of the methyl-es- rently, used as standard. terified dynorphin fragments are shown at the left of Table 1. Methyl esters were prepared readily for several fragments, Potency was significantly decreased after the removal oflysine- because the terminal a-COOH is the only acidic group in the 13, lysine-il, and arginine-7. The successive reductions in po- dynorphin-(1-13) sequence. Peptide was dissolved in anhy- tency were about 50%, 25%, and nearly 99%, respectively. drous methanol equilibrated with dry HG1 gas. The reaction Because removal of the other amino acids in the sequence did mixture was fractionated on a C18 reverse-phase HPLC column not significantly affect the potency, this analysis suggests these with the gradient conditions described above. In each case the three amino acids are largely responsible for the potency en- HPLC eluate contained two absorbance peaks, one in the po- hancement, with arginine-7 making the greatest contribution. sition of the parent peptide and a second retained 1-5 min The potencies of the nonesterified dynorphin fragments are longer. This second peak, eluting as expected for the more hy- also shown in Table 1. In this series, removal ofthe COOH-ter- drophobic ester, was purified to homogeneity as before by re- minal amino acid affected potency both by removing the amino peated HPLC. The resulting peptides were shown to be methyl acid functional group and by repositioning the COOH-terminal ester derivatives by saponification; with 90% or greater recov- negative charge. As with the methyl ester dynorphin fragments, ery, the parent (free carboxylic acid) peptide was generated. relative potency was significantly decreased by removal of lys- Potencies ofthe peptides were evaluated by using the guinea ine-13, lysine-li, and arginine-7. Here, however, removal of pig ileum myenteric plexus-longitudinal muscle bioassay as leucine-12 and arginine-6 had the opposite effect of increasing described (7). The concentration of each peptide required to the potency, an effect not seen in the methyl ester series. inhibit the muscle twitch by 50% (IC50) was determined by test- The contribution of the COOH-terminal negative charge to ing at three or more concentrations giving 20-80% inhibition these potency changes can be estimated by comparing the po- and then interpolating ICG5 by log-linear regression analysis. tencies of the COOH-terminal acids and methyl esters of each Agonist effects of all the peptides were reversed by naloxone. peptide. As shown in the last column ofTable 1, methyl ester- Naloxone sensitivity was determined by measuring IC50 in the ification did not significantly change the IC50 of dynorphin- presence and absence of 100 nM naloxone. Peptides were di- (1-13), -(1-11), -(1-6), or -(1-5). However, the potencies ofdy- luted in MeOH/0. 1 M HCl, 1:1 (vol/vol), which, in doses less norphin-(1-12), -(1-10), -(1-9), -(1-8), and -(1-7) were enhanced than 20 ,ul in the 5-ml bath, has no effect on the amplitude of 7- to 13-fold, indicating that the COOH-terminal negative contraction.
Load more

Recommended publications
  • Characterisation and Partial Purification of a Novel Prohormone Processing Enzyme from Ovine Adrenal Medulla
    Volume 246, number 1,2, 44-48 FEB 06940 March 1989 Characterisation and partial purification of a novel prohormone processing enzyme from ovine adrenal medulla N. Tezapsidis and D.C. Parish Biochemistry Group, School of Biological Sciences, University of Sussex, Falmer, Brighton, Sussex, England Received 3 January 1989 An enzymatic activity has been identified which is capable of generating a product chromatographically identical with adrenorphin from the model substrate BAM 12P. This enzyme was purified by gel filtration and ion-exchange chromatog- raphy and characterised as having a molecular mass between 30 and 45 kDa and an acidic pL The enzyme is active at the acid pH expected in the secretory vesicle interior and is inhibited by EDTA, suggesting that it is a metalloprotease. This activity could not be mimicked by incubation with lysosomal fractions and it meets the criteria to be considered as a possible prohormone processing enzyme. Prohormone processing; Adrenorphin; Secretory vesiclepurification 1. INTRODUCTION The purification of an endopeptidase responsi- ble for the generation of adrenorphin was under- Active peptide hormones are released from their taken, using the ovine adrenal medulla as a source. precursors by endoproteolytic cleavage at highly Adrenorphin is known to be located in the adrenal specific sites. The commonest of these is cleavage medulla of all species so far investigated [6]. at pairs of basic residues such as lysine and Secretory vesicles (also known as chromaffin arginine [1,2]. However another common class of granules) were isolated as a preliminary purifica- processing sites are known to be at single arginine tion step, since it is known that prohormone pro- residues, adjacent to a proline [3].
    [Show full text]
  • From Opiate Pharmacology to Opioid Peptide Physiology
    Upsala J Med Sci 105: 1-16,2000 From Opiate Pharmacology to Opioid Peptide Physiology Lars Terenius Experimental Alcohol and Drug Addiction Section, Department of Clinical Neuroscience, Karolinsku Institutet, S-I71 76 Stockholm, Sweden ABSTRACT This is a personal account of how studies of the pharmacology of opiates led to the discovery of a family of endogenous opioid peptides, also called endorphins. The unique pharmacological activity profile of opiates has an endogenous counterpart in the enkephalins and j3-endorphin, peptides which also are powerful analgesics and euphorigenic agents. The enkephalins not only act on the classic morphine (p-) receptor but also on the 6-receptor, which often co-exists with preceptors and mediates pain relief. Other members of the opioid peptide family are the dynor- phins, acting on the K-receptor earlier defined as precipitating unpleasant central nervous system (CNS) side effects in screening for opiate activity, A related peptide, nociceptin is not an opioid and acts on the separate NOR-receptor. Both dynorphins and nociceptin have modulatory effects on several CNS functions, including memory acquisition, stress and movement. In conclusion, a natural product, morphine and a large number of synthetic organic molecules, useful as drugs, have been found to probe a previously unknown physiologic system. This is a unique develop- ment not only in the neuropeptide field, but in physiology in general. INTRODUCTION Historical background Opiates are indispensible drugs in the pharmacologic armamentarium. No other drug family can relieve intense, deep pain and reduce suffering. Morphine, the prototypic opiate is an alkaloid extracted from the capsules of opium poppy.
    [Show full text]
  • 213393336.Pdf
    The Development of Analytical Methods for Investigations of Dynorphin A 1-17 Metabolism in the Central Nervous System and Peripheral Tissues and Transport at the Blood Brain Barrier By Courtney D. Kuhnline Sloan B.S., Investigative and Medical Sciences and Chemistry, Saint Louis University, 2005 M.S., Pharmaceutical Chemistry, The University of Kansas, 2008 Submitted to the Department of Pharmaceutical Chemistry and the faculty of the Graduate School of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________ Chairperson- Dr. Susan M. Lunte ________________________________ Dr. Kenneth L. Audus ________________________________ Dr. John F. Stobaugh ________________________________ Dr. Teruna J. Siahaan ________________________________ Dr. Jane V. Aldrich Dissertation Defense: February 11, 2011 The Dissertation Committee for Courtney Kuhnline Sloan certifies that this is the approved version of the following dissertation: The Development of Analytical Methods for Investigations of Dynorphin A 1-17 Metabolism, in the Central Nervous System and Peripheral Tissues, and Transport at the Blood Brain Barrier ________________________________ Chairperson- Dr. Susan M. Lunte Date approved:_______________________ ii This dissertation is dedicated to my parents, Pam and Mike Kuhnline, for always pushing me to do my absolute best at everything I have ever attempted, and to my husband, Patrick, for his continual encouragement and willingness to spend our first months as a married couple with me buried under my thesis. This work was possible because of the unconditional love and support I have been so fortunate to have from each of you. iii Abstract Dynorphin A 1-17 (Dyn A 1-17) is an endogenous neuropeptide that acts preferentially at the kappa opioid receptor.
    [Show full text]
  • Opposing Roles of Cotransmission of Dynorphin and Hypocretin on Reward and Motivation Xuan Li1, Nathan J
    COMMENTARY COMMENTARY Opposing roles of cotransmission of dynorphin and hypocretin on reward and motivation Xuan Li1, Nathan J. Marchant, and Yavin Shaham1 Behavioral Neuroscience Research Branch, Intramural Research Program, Department of A Brain stimulation Cocaine self- reward administration Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baseline Impulsive behavior Baltimore, MD 21224 Hypocretin Dynorphin In PNAS, Muschamp et al. (1) report that sleep homeostasis (12), and—most relevant HCRTR1 antagonist: KOR signal dominates hypocretin and dynorphin are coexpressed in to the present study—the rewarding effects the same synaptic vesicles of hypothalamic of cocaine and other rewards via its action neurons. Their data from behavioral, phar- on VTA dopamine neurons (13, 14). macological, and electrophysiological studies In 2001, Chou et al. (15) reported that HCRTR1 antagonist + KOR antagonist: Balance restored suggest that hypocretin and dynorphin are hypocretin and dynorphin colocalize in the coreleased, and that they play opposing roles same hypothalamic neurons (15). In 2006, Li in cocaine self-administration, brain stimula- and van den Pol (16) extended these findings ’ tion reward, and impulsivity. The authors and provided electrophysiological data in- B Ventral tegmental area: data also suggest that the critical brain site for dicating that inhibitory dynorphin and ex- these opposing effects of coreleased hypocre- citatory hypocretin are simultaneously tin and dynorphin is the ventral tegmental coreleased after stimulation of hypothalamic area (VTA), the cell body region of the hypocretin neurons. The functional signifi- mesolimbic dopamine reward system (2). cance of hypocretin/dynorphin corelease is un- Fig. 1 provides a summary of the main find- known, because despite the above-mentioned ings from the study.
    [Show full text]
  • The Role of Protein Convertases in Bigdynorphin and Dynorphin a Metabolic Pathway
    Université de Montréal The Role of Protein Convertases in Bigdynorphin and Dynorphin A Metabolic Pathway par ALBERTO RUIZ ORDUNA Département de biomédecine vétérinaire Faculté de médecine vétérinaire Mémoire présenté à la Faculté de médecine vétérinaire en vue de l’obtention du grade de maître ès sciences (M.Sc.) en sciences vétérinaires option pharmacologie Décembre, 2015 © Alberto Ruiz Orduna, 2015 Résumé Les dynorphines sont des neuropeptides importants avec un rôle central dans la nociception et l’atténuation de la douleur. De nombreux mécanismes régulent les concentrations de dynorphine endogènes, y compris la protéolyse. Les Proprotéines convertases (PC) sont largement exprimées dans le système nerveux central et clivent spécifiquement le C-terminale de couple acides aminés basiques, ou un résidu basique unique. Le contrôle protéolytique des concentrations endogènes de Big Dynorphine (BDyn) et dynorphine A (Dyn A) a un effet important sur la perception de la douleur et le rôle de PC reste à être déterminée. L'objectif de cette étude était de décrypter le rôle de PC1 et PC2 dans le contrôle protéolytique de BDyn et Dyn A avec l'aide de fractions cellulaires de la moelle épinière de type sauvage (WT), PC1 -/+ et PC2 -/+ de souris et par la spectrométrie de masse. Nos résultats démontrent clairement que PC1 et PC2 sont impliquées dans la protéolyse de BDyn et Dyn A avec un rôle plus significatif pour PC1. Le traitement en C-terminal de BDyn génère des fragments peptidiques spécifiques incluant dynorphine 1-19, dynorphine 1-13, dynorphine 1-11 et dynorphine 1-7 et Dyn A génère les fragments dynorphine 1-13, dynorphine 1-11 et dynorphine 1-7.
    [Show full text]
  • The Role of Dynorphin in the Onset of Puberty in Female Lambs
    Graduate Theses, Dissertations, and Problem Reports 2015 The Role of Dynorphin in the Onset of Puberty in Female Lambs Justin Angelo Lopez Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Lopez, Justin Angelo, "The Role of Dynorphin in the Onset of Puberty in Female Lambs" (2015). Graduate Theses, Dissertations, and Problem Reports. 6110. https://researchrepository.wvu.edu/etd/6110 This Thesis is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Thesis in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Thesis has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. The Role of Dynorphin in the Onset of Puberty in Female Lambs by Justin Angelo Lopez Thesis submitted to the Davis College of Agriculture, Natural Resources and Design at West Virginia University in partial fulfillment of the requirements for the degree of Master of Science in Reproductive Physiology Robert L. Goodman, Ph.D., Chair Stanley M. Hileman, Ph.D. Robert A. Dailey, Ph.D. Reproductive Physiology Morgantown, West Virginia 2015 Keywords: sheep, puberty, dynoprhin, kisspeptin, KNDy Copyright 2015 Justin Angelo Lopez ABSTRACT The Role of Dynorphin in the Onset of Puberty in Female Lambs Justin Angelo Lopez The neural mechanisms underlying the onset of puberty are not well understood.
    [Show full text]
  • Endorphin in Feeding and Diet-Induced Obesity
    Neuropsychopharmacology (2015) 40, 2103–2112 © 2015 American College of Neuropsychopharmacology. All rights reserved 0893-133X/15 www.neuropsychopharmacology.org Involvement of Endogenous Enkephalins and β-Endorphin in Feeding and Diet-Induced Obesity ,1 1,2 1 1 Ian A Mendez* , Sean B Ostlund , Nigel T Maidment and Niall P Murphy 1 Hatos Center, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of 2 California, Los Angeles, Los Angeles, CA, USA; Department of Anesthesiology and Perioperative Care, University of California, Irvine, Irvine, CA, USA Studies implicate opioid transmission in hedonic and metabolic control of feeding, although roles for specific endogenous opioid peptides have barely been addressed. Here, we studied palatable liquid consumption in proenkephalin knockout (PENK KO) and β-endorphin- deficient (BEND KO) mice, and how the body weight of these mice changed during consumption of an energy-dense highly palatable ‘ ’ cafeteria diet . When given access to sucrose solution, PENK KOs exhibited fewer bouts of licking than wild types, even though the length of bouts was similar to that of wild types, a pattern that suggests diminished food motivation. Conversely, BEND KOs did not differ from wild types in the number of licking bouts, even though these bouts were shorter in length, suggesting that they experienced the sucrose as being less palatable. In addition, licking responses in BEND, but not PENK, KO mice were insensitive to shifts in sucrose concentration or hunger. PENK, but not BEND, KOs exhibited lower baseline body weights compared with wild types on chow diet and attenuated weight gain when fed cafeteria diet.
    [Show full text]
  • [Leu ] Enkephalin Enhances Active Avoidance Conditioning in Rats and Mice Patricia H
    NEUROPSYCHOPHARMACOLOGY 1994-VOL. 10, NO. 1 53 [Leu ] Enkephalin Enhances Active Avoidance Conditioning in Rats and Mice Patricia H. Janak, Ph.D., Jennifer J. Manly, and Joe L. Martinez, Jr., Ph.D. The effects of intraperitoneal (IP) administration of the jump-up one-way active avoidance response. When endogenous opioid peptide, [Leu1enkephalin (LE), on administered to Sprague-Dawley rats immediately after avoidance conditioning in rodents were investigated. At a training, LE (30 /lglkg IP) enhanced jump-up avoidance dose of 30 /lglkg (IP), LE enhanced acquisition of a responding at test 24 hours after peptide injection. one-way step-through active avoidance response when Previously, we found LE to impair acquisition in the administered 2 minutes before training to Swiss Webster same tasks in both rats and mice, also at microgram mice. [Leu1enkephalin produced aU-shaped doses, and also in a U-shaped manner. Thus, LE can dose-response function because both lower and higher either enhance or impair learning within the same species doses of LE did not affect avoidance responding. and the same task; these findings are in agreement with fLeu1enkephalin-induced enhancement of avoidance recent theoretical proposals regarding the nature of acquisition was also observed in Sprague-Dawley rats; compounds, such as LE, that modulate learning and the intraperitoneal injection of 10 /lglkg LE, administered memory. [Neuropsychopharmacology 10:53-60, 19941 5 minutes before training, enhanced acquisition of a KEY WORDS: Enkephalin; Aversive conditioning; improve or worsen learning and memory (Martinez et Acquisition; Retention; Learning; Memory; Rat; Mouse al. 1991a; Schulteis et al. 1990; Schulteis and Martinez 1992a; Gold 1989).
    [Show full text]
  • Calcitonin Gene-Related Peptide and Other Peptides
    P1: KWW/KKL P2: KWW/HCN QC: KWW/FLX T1: KWW GRBT050-16 Olesen- 2057G GRBT050-Olesen-v6.cls July 9, 2005 4:30 ••Chapter 16 ◗ Calcitonin Gene-Related Peptide and Other Peptides Susan Brain and Lars Edvinsson Vasoactive peptides can be either stored or synthesized de THE CGRP FAMILY OF PEPTIDES novo before release from a range of tissues in the brain or from the walls of intracranial vasculature. In this chapter, The expression of mRNA from the calcitonin gene is tissue we concentrate on neuropeptides that are released from specific in that CGRP mRNA is predominantly expressed perivascular nerves. These include calcitonin gene-related in nerves and calcitonin mRNA in the thyroid (5). The 37 peptide (CGRP), substance P, neurokinin A, nociceptin, amino acid peptide CGRP belongs to a family that include somatostatin, and opioids (Table 16-1). The endothelium the more recently discovered peptides adrenomedullin produces the potent vasoconstrictors endothelin and an- that is primarily produced by non-neuronal tissues, espe- giotensin, and dilators such as nitric oxide, prostacyclin, cially vascular tissues and amylin that is mainly produced and endothelium-derived hyperpolarizing factors. In ad- in the pancreas. They share some structural homology (ap- dition there are circulating agents; among these the most proximately 25–40%) and also some, but not total, similar- potent is 5-hydroxytryptamine. The neuronal messengers ities in biological activities (see Brain and Grant [11] for stored in the intracranial vessels have been reviewed recent review). CGRP is abundant in the body and has a (32) and it was revealed that sympathetic nerves store wide distribution throughout the central and peripheral noradrenaline, neuropeptide Y, and ATP, the parasympa- nervous systems.
    [Show full text]
  • Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions
    Molecular Pharmacology Fast Forward. Published on June 2, 2020 as DOI: 10.1124/mol.120.119388 This article has not been copyedited and formatted. The final version may differ from this version. File name: Opioid peptides v45 Date: 5/28/20 Review for Mol Pharm Special Issue celebrating 50 years of INRC Five decades of research on opioid peptides: Current knowledge and unanswered questions Lloyd D. Fricker1, Elyssa B. Margolis2, Ivone Gomes3, Lakshmi A. Devi3 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; E-mail: [email protected] 2Department of Neurology, UCSF Weill Institute for Neurosciences, 675 Nelson Rising Lane, San Francisco, CA 94143, USA; E-mail: [email protected] 3Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Annenberg Downloaded from Building, One Gustave L. Levy Place, New York, NY 10029, USA; E-mail: [email protected] Running Title: Opioid peptides molpharm.aspetjournals.org Contact info for corresponding author(s): Lloyd Fricker, Ph.D. Department of Molecular Pharmacology Albert Einstein College of Medicine 1300 Morris Park Ave Bronx, NY 10461 Office: 718-430-4225 FAX: 718-430-8922 at ASPET Journals on October 1, 2021 Email: [email protected] Footnotes: The writing of the manuscript was funded in part by NIH grants DA008863 and NS026880 (to LAD) and AA026609 (to EBM). List of nonstandard abbreviations: ACTH Adrenocorticotrophic hormone AgRP Agouti-related peptide (AgRP) α-MSH Alpha-melanocyte stimulating hormone CART Cocaine- and amphetamine-regulated transcript CLIP Corticotropin-like intermediate lobe peptide DAMGO D-Ala2, N-MePhe4, Gly-ol]-enkephalin DOR Delta opioid receptor DPDPE [D-Pen2,D- Pen5]-enkephalin KOR Kappa opioid receptor MOR Mu opioid receptor PDYN Prodynorphin PENK Proenkephalin PET Positron-emission tomography PNOC Pronociceptin POMC Proopiomelanocortin 1 Molecular Pharmacology Fast Forward.
    [Show full text]
  • Calcitonin Gene-Related Peptide Regulates Expression of Neurokinin1 Receptors by Rat Spinal Neurons
    1816 • The Journal of Neuroscience, March 1, 2003 • 23(5):1816–1824 Calcitonin Gene-Related Peptide Regulates Expression of Neurokinin1 Receptors by Rat Spinal Neurons Virginia S. Seybold,1 Kenneth E. McCarson,2 Paul G. Mermelstein,1 Rachel D. Groth,1 and Lia G. Abrahams1 1Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, and 2Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160 Although neurokinin 1 (NK1) receptors contribute to hyperalgesia, and their expression is increased in the spinal cord during peripheral inflammation, little is known regarding the signaling molecules and the second messenger pathways that they activate in regulating the expression of the NK1 receptor gene. Because the promoter region of the NK1 receptor contains a cAMP response element (CRE), we tested the hypothesis that calcitonin gene-related peptide (CGRP) regulates the expression of NK1 receptors via a pathway involving activation of the transcription factor cAMP response element binding protein (CREB). Experiments were conducted on primary cultures of neonatal rat spinal neurons. Treatment of cultures with CGRP for 8–24 hr increased 125I-substance P binding on spinal neurons; the increase in binding was preceded by an elevation in NK1 receptor mRNA. The CGRP-induced change in 125I-substance P binding was concentration-dependent and was inhibited by the antagonist CGRP8–37. CGRP increased phosphorylated CREB immunoreactivity and CRE-dependent transcription in neurons, indicating the involvement of the transcription factor CREB. Evidence that CGRP increased cAMP levels in spinal neurons and that the protein kinase A inhibitor H89 attenuated CGRP-induced CRE-dependent transcription suggests that the intracellular pathway stimulated by CGRP leads to activation of protein kinase A.
    [Show full text]
  • Distribution of Prodynorphin Mrna and Its Interaction with the NPY System in the Mouse Brain Neuropeptides 40 (2): 115-123, 2006
    Lin et al.: Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain Neuropeptides 40 (2): 115-123, 2006 Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain Shu Lina, Dana Boeya, Nicola Leea, Christoph Schwarzerb, Amanda Sainsburya, Herbert Herzoga, a Neurobiology Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australiab Department of Pharmacology, Medical University of Innsbruck, Peter- Mayr-Strasse 1a, 6020 Innsbruck, Austria Abstract Using radioactive in situ hybridisation, the distribution of prodynorphin mRNA in the brains of C57Bl/6 mice was systemically investigated, and double-labelling in situ hybridisation was used to determine the extent to which neuropeptide Y (NPY) and prodynorphin mRNAs were co-expressed. Our results demonstrate that prodynorphin mRNA expression in the mouse brain is localised at specific subregions of the olfactory bulb, cortex, hippocampus, amygdala, basal ganglia, thalamus, hypothalamus, mesencephalon and myelencephalon. Among the regions displaying the most intense labelling were the olfactory tubercle, lateral septum (LS), caudate putamen (Cpu), central amygdaloid nucleus (Ce), paraventricular hypothalamic nucleus (PVN), supraoptic nucleus (SO), lateral hypothalamic area (LHA), ventromedial hypothalamic nucleus (VMH), lateral reticular nucleus (LRt) and solitary tract nucleus (NTS). In the arcuate nucleus of the hypothalamus (Arc), double- labelling in situ hybridisation revealed that prodynorphin expressing neurons also contained NPY mRNA, with a co-localisation rate of approximately 88% in the lateral part of the Arc, and 79% in the dorsal part of the Arc, respectively, suggesting potential overlapping functions of these two neurotransmitters in feeding type behaviour.
    [Show full text]